Login to Your Account

NewCo News

Patient Associations Fostering Halo's Effect in DMD Space

By Jennifer Boggs
Managing Editor

Thursday, May 3, 2012
For companies working in orphan diseases, support from patient advocacy groups and foundations is critical, both in terms of providing much-needed funding and building relationships with the small patient communities. But 2011 start-up Halo Therapeutics LLC credits its connection to patient groups to the company's actual formation.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription